Semaglutide for better embryos in IVF for women with overweight or obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether semaglutide, a medication used for weight management, can improve the quality of embryos in women who are overweight or have obesity and are doing IVF. It aims to see if taking semaglutide before the IVF process helps make healthier embryos that can be frozen for later use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 38 years old or younger.
- Your BMI is between 27 and 40.
- You have a good ovarian reserve (AMH level of 1 ng/mL or higher, or AFC count of 6 or more).
- You are planning to have IVF and freeze all embryos (a freeze-all strategy).
- You have not used a GLP-1 medication (like Ozempic or Wegovy) in the past year.
- You do not have type 2 diabetes or uncontrolled thyroid problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests if a weekly injection called semaglutide can help women with PCOS and obesity lose weight and improve their health. It is for women who do not have other serious medical conditions.
This study tests an injectable medication called semaglutide to help with weight loss in people with a BMI of 28 or higher who have struggled to lose weight before. It compares the study drug to a similar approved weight loss medicine (Wegovy).
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This trial tests if semaglutide (a weekly injection) helps people who lost less weight than expected after gastric bypass or sleeve surgery. It's for patients who had a high BMI before surgery and are in a special support program.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.